- Home
- BCRX vs STEW Comparison
BCRX vs STEW Comparison
Compare BCRX & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- STEW
- Stock Information
- Founded
- BCRX 1986
- STEW 1972
- Country
- BCRX United States
- STEW United States
- Employees
- BCRX N/A
- STEW N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- STEW Investment Managers
- Sector
- BCRX Health Care
- STEW Finance
- Exchange
- BCRX Nasdaq
- STEW Nasdaq
- Market Cap
- BCRX 1.7B
- STEW 1.6B
- IPO Year
- BCRX 1994
- STEW N/A
- Fundamental
- Price
- BCRX $7.86
- STEW $17.16
- Analyst Decision
- BCRX Buy
- STEW
- Analyst Count
- BCRX 6
- STEW 0
- Target Price
- BCRX $15.67
- STEW N/A
- AVG Volume (30 Days)
- BCRX 3.6M
- STEW 84.5K
- Earning Date
- BCRX 05-05-2025
- STEW 01-01-0001
- Dividend Yield
- BCRX N/A
- STEW 3.71%
- EPS Growth
- BCRX N/A
- STEW N/A
- EPS
- BCRX N/A
- STEW 1.44
- Revenue
- BCRX $450,712,000.00
- STEW N/A
- Revenue This Year
- BCRX $27.66
- STEW N/A
- Revenue Next Year
- BCRX $13.59
- STEW N/A
- P/E Ratio
- BCRX N/A
- STEW $10.34
- Revenue Growth
- BCRX 36.00
- STEW N/A
- 52 Week Low
- BCRX $4.03
- STEW $11.97
- 52 Week High
- BCRX $9.50
- STEW $14.94
- Technical
- Relative Strength Index (RSI)
- BCRX 46.95
- STEW 64.36
- Support Level
- BCRX $7.44
- STEW $16.51
- Resistance Level
- BCRX $8.12
- STEW $17.46
- Average True Range (ATR)
- BCRX 0.27
- STEW 0.21
- MACD
- BCRX 0.03
- STEW 0.09
- Stochastic Oscillator
- BCRX 71.74
- STEW 80.00
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.